Zobrazeno 1 - 10
of 80
pro vyhledávání: '"John G. Gambertoglio"'
Autor:
Francesca T. Aweeka, John G. Gambertoglio, Anne Hedman, Patricia Schoenfeld, Sarah Martin-Munley, Rodney Omachi, Mark A. Jacobson, Shirley M. Tsunoda
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 20:350-357
Background Foscarnet is an antiviral agent commonly used for managing patients with cytomegalovirus infection. Despite its clinical usefulness, foscarnet is associated with substantial adverse effects including nephrotoxicity. Moreover, foscarnet is
Autor:
John G. Gambertoglio, Patricia Schoenfeld, Suzanne R. Brody, Kenneth C. Cundy, Michael H. Humphreys, Francesca T. Aweeka
Publikováno v:
Clinical Pharmacology & Therapeutics. 65:21-28
Background Cidofovir is an antiviral agent used for the treatment of cytomegalovirus infection in patients with acquired immunodeficiency syndrome. Because cidofovir is primarily eliminated by the kidneys and because its main adverse effect is nephro
Publikováno v:
Journal of Liquid Chromatography & Related Technologies. 21:2947-2956
The size of intracellular 2′-deoxythymidine-5′-triphosphate (dTTP) pools is an important indicator of cytotoxicity in cells exposed to antiviral drugs and mutagens. We describe an ion paired reverse-phase high performance liquid chromatographic (
Autor:
John G. Gambertoglio, Katrin Peter
Publikováno v:
Pharmaceutical Research. 15:819-825
Dramatic reductions of viral load and increased survival have been achieved in patients infected with the Human Immunodeficiency Virus (HIV) with the introduction of combination antiretroviral therapy. Currently 11 agents including nucleoside reverse
Autor:
John G. Gambertoglio, Mae Kwong, May Mak, David L. Cutler, James O. Kahn, Mel Affrime, Francesca T. Aweeka, Almira Al-Uzri
Publikováno v:
The Journal of Clinical Pharmacology. 36:1107-1113
Recombinant human granulocyte-macrophage colony-stimulating factor (rHu GM-CSF) enhances bone marrow production of and stimulates granulocytes, macrophages, and eosinophils. Granulocyte-macrophage colony-stimulating factor may be used concomitantly w
Autor:
John G. Gambertoglio, Thomayant Prueksaritanont, Stephen J. Tomlanovich, Marvin R. Garovoy, Suneel K. Gupta, Francesca T. Aweeka, Marianne Lantz, Claudia H. d'Uscio, Leslie Z. Benet
Publikováno v:
The Journal of Clinical Pharmacology. 35:967-973
The immunopharmacodynamics of cyclosporine were investigated in eight hemodialysis patients awaiting renal transplantation. Cyclosporine was administered orally (10 mg/kg) and intravenously (4 mg/kg), with both administrations separated by at least o
Autor:
James O. Kahn, Francesca T. Aweeka, Katrin Peter, May Mak, Melton B. Affrime, Amira Al-Uzri, Carmen Dett, David L. Cutler, Roberto Guerciolini, John G. Gambertoglio, Jose Franco
Publikováno v:
The Journal of Clinical Pharmacology. 35:856-864
Combination therapy with zidovudine and recombinant human granulocyte-macrophage colony stimulating factor (rHu GM-CSF) may be warranted, owing to the bone marrow suppressive effects of zidovudine. A study of 16 patients, 8 of whom had acquired immun
Autor:
Patricia Lizak, Anura L. Jayewardene, Françoise Kramer, Charles van der Horst, John G. Gambertoglio, Bruce Polsky, Francesca T. Aweeka, William Tong, Lisa Emrick, Mark A. Jacobson
Publikováno v:
Clinical Pharmacology & Therapeutics. 57:403-412
Introduction The use of foscarnet and ganciclovir as a combination treatment for cytomegalovirus retinitis is increasing because of limitations associated with single agent therapy. Methods The pharmacokinetics of foscarnet and ganciclovir were deter
Autor:
John G. Gambertoglio, John F. Flaherty, Y. W. Francis Lam, Patricia Y. Schoenfeld, Lucy Yumena
Publikováno v:
Journal of Antimicrobial Chemotherapy. 36:157-163
Roxithromycin is a macrolide antibiotic with a spectrum of activity similar to erythromycin. Roxithromycin has been shown to have a favourable pharmacokinetic profile with more reliable absorption and higher, prolonged plasma and tissue concentration
Publikováno v:
Journal of Liquid Chromatography. 17:4157-4167
An ion paired reversed - phase high performance liquid chromatographic assay for ceftizoxime in human abscess fluid using barbital as the internal standard is described. Sample preparation consists of precipitating the proteins in diluted abscess flu